17 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Sep 2030. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Sep 2030
Next term end
9
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2031 · High confidence
Also notable
Ends Feb 2033 · High confidence
Also notable
Ends Aug 2031 · High confidence
Methods for Preparing Purified Polypeptide Compositions
US 9,206,223
The most cited patent in this portfolio, cited by 95 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2031.
Peptidomimetic Macrocycles
US 8,927,500
Cited by 61 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Peptidomimetic Macrocycles
US 8,859,723
Cited by 47 later US patents, top 25% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 28, 2026The maintenance fee for Peptidomimetic Macrocycles (US 10,300,109) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
- 1 fee due May 12, 2027The maintenance fee for Peptidomimetic Macrocycles and Uses Thereof (US 10,471,120) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 1 fee due Jun 8, 2027The maintenance fee for Methods for Preparing Purified Polypeptide Compositions (US 9,206,223) comes due Jun 8, 2027. Unpaid by Dec 8, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Peptidomimetic Macrocycles (2013) | 4 in force | to Feb 2033 |
| Disubstituted Amino Acids and Methods of Preparation and Use Thereof | 3 in force | to Nov 2033 |
| Peptidomimetic Macrocycles (2013) | 3 in force | to Aug 2031 |
| Triazole-Crosslinked and Thioether-Crosslinked Peptidomimetic Macrocycles | 2 in force | to Feb 2033 |
| Peptidomimetic Macrocycles and Uses Thereof | 1 in force | to Aug 2036 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,300,109 | Peptidomimetic Macrocycles In force · Medium confidence | In force | Medium confidence | |
| US 9,206,223 | Methods for Preparing Purified Polypeptide Compositions In force · High confidence | In force | High confidence | |
| US 8,859,723 | Peptidomimetic Macrocycles In force · High confidence | In force | High confidence | |
| US 9,957,299 | Peptidomimetic Macrocycles In force · High confidence | In force | High confidence | |
| US 11,008,366 | Peptidomimetic Macrocycles In force · High confidence | In force | High confidence | |
| US 8,927,500 | Peptidomimetic Macrocycles In force · High confidence | In force | High confidence | |
| US 8,987,414 | Triazole-Crosslinked and Thioether-Crosslinked Peptidomimetic Macrocycles In force · High confidence | In force | High confidence | |
| US 9,505,804 | Peptidomimetic Macrocycles In force · High confidence | In force | High confidence | |
| US 10,213,477 | Peptidomimetic Macrocycles In force · High confidence | In force | High confidence | |
| US 10,967,042 | Peptidomimetic Macrocycles In force · High confidence | In force | High confidence |
Also on record, not counted in the 17: 27 patents ended · 48 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.